Several Measures on Supporting the Implementation of Major Projects by Foreign-Invested Biopharmaceutical Companies

Shanghai has introduced 25 measures to support major projects by foreign-invested biopharmaceutical companies, covering manufacturing, research and development, and headquarters operations. The measures target projects with large investment, strong innovation capacity, and broad industry impact.

Issuing Authority: Shanghai Municipal Commission of Science and Technology, Shanghai Municipal Development and Reform Commission, Shanghai Municipal Commission of Commerce, Shanghai Municipal Commission of Health, Shanghai Municipal Medical Products Administration

Issued on: June 23, 2026

Effective Date: June 23, 2026 – June 21, 2029

Applicable Area: Municipality-wide

Type: Local Policy

Chinese

• Shanghai unveils measures to support major foreign-invested biopharmaceutical projects